Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PTTG1 as a common promising target for PCOS, Ovarian Cancer, and Major Depressive Disorder patients. | Comput Biol Chem | 2026 | 40925190 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers Related to the Progression and Prognosis of Parkinson's Disease and Melanoma via Combined System Biology Approaches. | Biotechnol Appl Biochem | 2026 | 40879648 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing via endoscopic ultrasound-guided fine-needle biopsy for pancreatic tumors uncovered an aggressive subclone with a poor prognosis. | ESMO Gastrointest Oncol | 2025 | 41646484 | PubTator, text mining | PubMed |
| Integrative Bioinformatics and Experimental Validation Establish CCNB1 as a Potential Biomarker for Diagnosis and Prognosis in Colorectal Cancer. | Curr Issues Mol Biol | 2025 | 41614789 | PubTator, text mining | PubMed |
| RETRACTION: UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells. | J Oncol | 2025 | 41497216 | PubTator, text mining | PubMed |
| Rank Aggregation Methods and Tools in Genomic Data Analysis. | Curr Genomics | 2025 | 41450822 | PubTator, text mining | PubMed |
| Identification of key candidate genes for ovarian cancer using integrated statistical and machine learning approaches. | Brief Bioinform | 2025 | 41405958 | PubTator, text mining | PubMed |
| Development and Validation of an Intratumor Heterogeneity-Based Prognostic Model for Clear Cell Renal Cell Carcinoma. | JCO Precis Oncol | 2025 | 41370731 | PubTator, text mining | PubMed |
| Enhancement of activation-induced T cell proliferation by SIRPG in a CD47-independent manner. | Front Immunol | 2025 | 41357240 | PubTator, text mining | PubMed |
| Single-cell RNA-seq combined with bulk RNA-seq explores shared gene signatures between thyroid and breast cancers. | Front Genet | 2025 | 41328437 | PubTator, text mining | PubMed |
| Learning in Probabilistic Boolean Networks via Structural Policy Gradients. | Entropy (Basel) | 2025 | 41294993 | PubTator, text mining | PubMed |
| A Mendelian randomization-based risk model using aging-related genes for prognosis in lung adenocarcinoma. | Discov Oncol | 2025 | 41284116 | PubTator, text mining | PubMed |
| Integrated analysis reveals survival-related genes promoting cholangiocarcinoma progression via G2/M cell cycle, with validation of cyclin B1 in tumor proliferation. | Sci Rep | 2025 | 41272097 | PubTator, text mining | PubMed |
| SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer. | Carcinogenesis | 2025 | 41225668 | PubTator, text mining | PubMed |
| FOXM1 Facilitates NSCLC Tumorigenesis Through the Transcriptional Regulation of UBE2C. | FASEB J | 2025 | 41222961 | PubTator, text mining | PubMed |
| Genetic markers and canonical pathways associated with medulloblastoma: a systematic review and meta-analysis. | Transl Pediatr | 2025 | 41216458 | PubTator, text mining | PubMed |
| Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations. | Explor Target Antitumor Ther | 2025 | 41216224 | PubTator, text mining | PubMed |
| Exploring the carcinogenic potential of bisphenol A in lung adenocarcinoma: molecular mechanisms, key gene insights, and immune microenvironment impacts. | Front Immunol | 2025 | 41181148 | PubTator, text mining | PubMed |
| Screening and verification of anti-programmed death-ligand 1 immunotherapy-sensitive genes in lung squamous cell carcinoma based on bioinformatics. | Int J Biol Markers | 2025 | 41147995 | PubTator, text mining | PubMed |
| Integrated transcriptomic and immunoinformatics analysis identifies tpx2, bub1b, and ube2c as diagnostic biomarkers and therapeutic targets in endometrial carcinoma. | Discov Oncol | 2025 | 41144123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=4